Exact Mass: 391.1774926

Exact Mass Matches: 391.1774926

Found 173 metabolites which its exact mass value is equals to given mass value 391.1774926, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Linopirdine

1-phenyl-3,3-bis[(pyridin-4-yl)methyl]-2,3-dihydro-1H-indol-2-one

C26H21N3O (391.1684536)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker D020011 - Protective Agents Same as: D04741

   

Hexylglutathione

2-Amino-5-((1-((carboxymethyl)amino)-3-(hexylthio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid

C16H29N3O6S (391.17769740000006)


D004791 - Enzyme Inhibitors

   

Flavoxate

2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylic acid

C24H25NO4 (391.178349)


A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist. [PubChem] G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D000089162 - Genitourinary Agents > D064804 - Urological Agents

   

Orysastrobin

Orysastrobin

C18H25N5O5 (391.18556)


D010575 - Pesticides > D005659 - Fungicides, Industrial > D000073739 - Strobilurins D016573 - Agrochemicals

   

N-desmethyltoremifene

(2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)(methyl)amine

C25H26ClNO (391.17028160000007)


N-desmethyltoremifene is a metabolite of toremifene. Toremifene citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body. Licensed in the United States under the brand name Fareston, toremifene citrate is FDA-approved for use in advanced breast cancer. It is also being evaluated for prevention of prostate cancer under the brand name Acapodene. (Wikipedia)

   

N-(1-Carboxy-3-carboxanilidopropyl)alanylproline

1-(2-{[1-carboxy-3-(phenyl-C-hydroxycarbonimidoyl)propyl]amino}propanoyl)pyrrolidine-2-carboxylate

C19H25N3O6 (391.174327)


   

Ancistrolikokine D

Ancistrolikokine D

C24H25NO4 (391.178349)


   
   

Ancistroheynine B

Ancistroheynine B

C24H25NO4 (391.178349)


   

Ancistrocongolensine

Ancistrocongolensine

C24H25NO4 (391.178349)


   

Ancistroheynine A

Ancistroheynine A

C24H25NO4 (391.178349)


   

N-Methylatalaphyllinine

N-Methylatalaphyllinine

C24H25NO4 (391.178349)


   

N-Methylcycloatalaphylline A

N-Methylcycloatalaphylline A

C24H25NO4 (391.178349)


   

Glycofoline|pyranofoline

Glycofoline|pyranofoline

C24H25NO4 (391.178349)


   

dehydrotylophorine

dehydrotylophorine

C24H25NO4 (391.178349)


   

6,5-O,O-didemethylancistroealaine A

6,5-O,O-didemethylancistroealaine A

C24H25NO4 (391.178349)


   

5-O-demethylhamatinine

5-O-demethylhamatinine

C24H25NO4 (391.178349)


   

(2R,3S)-3-hydroxy-2-methylbutanenitrile beta-D-glucopyranoside 6?-O-(2?S,3?R)-2?-ethyl-2?,3?-dihydroxybutyrate|microtropin A

(2R,3S)-3-hydroxy-2-methylbutanenitrile beta-D-glucopyranoside 6?-O-(2?S,3?R)-2?-ethyl-2?,3?-dihydroxybutyrate|microtropin A

C17H29NO9 (391.1842224)


   

ancistectorine A3

ancistectorine A3

C24H25NO4 (391.178349)


   
   
   

1,4,5-TRI-O-ACETYL-3,6-DI-O-METHYL-2-N-METHYLACETAMIDO-2-DEOXYHEXITOL (1-D)

1,4,5-TRI-O-ACETYL-3,6-DI-O-METHYL-2-N-METHYLACETAMIDO-2-DEOXYHEXITOL (1-D)

C17H29NO9 (391.1842224)


   
   
   

1-(4-Methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-9-yl)-4-methyl-5-phenyl-penta-2,4-dien-1-one

"NCGC00160310-01!1-(4-Methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-9-yl)-4-methyl-5-phenyl-penta-2,4-dien-1-one"

C24H25NO4 (391.178349)


   
   

Linopirdine

Linopirdine(DuP-996)

C26H21N3O (391.1684536)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker D020011 - Protective Agents Same as: D04741

   

O4-Pyridylhydroxybutyl-thymidine

O4-Pyridylhydroxybutyl-thymidine

C19H25N3O6 (391.174327)


   

3-Pyridylhydroxybutyl-thymidine

3-Pyridylhydroxybutyl-thymidine

C19H25N3O6 (391.174327)


   

O2-Pyridylhydroxybutyl-thymidine

O2-Pyridylhydroxybutyl-thymidine

C19H25N3O6 (391.174327)


   

Ala Asn Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Ala Asn Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Ala Gln Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Ala Ser Asn Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Ala Ser Gln Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Ala Ser Ser Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C14H25N5O8 (391.170305)


   

Ala Ser Thr Asn

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C14H25N5O8 (391.170305)


   

Ala Thr Asn Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Ala Thr Ser Asn

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C14H25N5O8 (391.170305)


   

Gly Asn Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Gly Gln Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Gly Gln Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Gly Ser Gln Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Gly Ser Thr Gln

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C14H25N5O8 (391.170305)


   

Gly Thr Asn Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Gly Thr Gln Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Gly Thr Ser Gln

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C14H25N5O8 (391.170305)


   

Gly Thr Thr Asn

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C14H25N5O8 (391.170305)


   
   

Asn Ala Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Asn Ala Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Asn Gly Thr Thr

(2S,3R)-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxybutanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Asn Ser Ala Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]propanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Asn Ser Thr Ala

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]propanoic acid

C14H25N5O8 (391.170305)


   

Asn Thr Ala Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]propanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Asn Thr Gly Thr

(2S,3R)-2-{2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]acetamido}-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Asn Thr Ser Ala

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]propanoic acid

C14H25N5O8 (391.170305)


   

Asn Thr Thr Gly

2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]acetic acid

C14H25N5O8 (391.170305)


   
   

Gln Ala Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Gln Gly Ser Thr

(2S,3R)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-hydroxypropanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Gln Gly Thr Ser

(2S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-hydroxybutanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Gln Ser Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]propanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Gln Ser Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]acetamido}-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Gln Ser Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]propanoic acid

C14H25N5O8 (391.170305)


   

Gln Ser Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]acetic acid

C14H25N5O8 (391.170305)


   

Gln Thr Gly Ser

(2S)-2-{2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]acetamido}-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Gln Thr Ser Gly

2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]acetic acid

C14H25N5O8 (391.170305)


   
   

Ser Ala Asn Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Ser Ala Gln Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Ser Ala Ser Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C14H25N5O8 (391.170305)


   

Ser Ala Thr Asn

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C14H25N5O8 (391.170305)


   

Ser Gly Gln Thr

(2S,3R)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Ser Gly Thr Gln

(2S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C14H25N5O8 (391.170305)


   

Ser Asn Ala Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]propanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Ser Asn Thr Ala

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]propanoic acid

C14H25N5O8 (391.170305)


   

Ser Gln Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]propanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Ser Gln Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]acetamido}-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Ser Gln Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]propanoic acid

C14H25N5O8 (391.170305)


   

Ser Gln Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxybutanamido]acetic acid

C14H25N5O8 (391.170305)


   

Ser Ser Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]propanamido]-4-carbamoylbutanoic acid

C14H25N5O8 (391.170305)


   

Ser Ser Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]propanoic acid

C14H25N5O8 (391.170305)


   

Ser Thr Ala Asn

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]propanamido]-3-carbamoylpropanoic acid

C14H25N5O8 (391.170305)


   

Ser Thr Gly Gln

(2S)-2-{2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]acetamido}-4-carbamoylbutanoic acid

C14H25N5O8 (391.170305)


   

Ser Thr Asn Ala

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]propanoic acid

C14H25N5O8 (391.170305)


   

Ser Thr Gln Gly

2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-4-carbamoylbutanamido]acetic acid

C14H25N5O8 (391.170305)


   

Thr Ala Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Thr Ala Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C14H25N5O8 (391.170305)


   

Thr Gly Asn Thr

(2S,3R)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Thr Gly Gln Ser

(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Thr Gly Ser Gln

(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C14H25N5O8 (391.170305)


   

Thr Gly Thr Asn

(2S)-2-[(2S,3R)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C14H25N5O8 (391.170305)


   
   

Thr Asn Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]propanamido]-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Thr Asn Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxybutanoic acid

C14H25N5O8 (391.170305)


   

Thr Asn Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]propanoic acid

C14H25N5O8 (391.170305)


   

Thr Asn Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]acetic acid

C14H25N5O8 (391.170305)


   

Thr Gln Gly Ser

(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]acetamido}-3-hydroxypropanoic acid

C14H25N5O8 (391.170305)


   

Thr Gln Ser Gly

2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]acetic acid

C14H25N5O8 (391.170305)


   

Thr Ser Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]propanamido]-3-carbamoylpropanoic acid

C14H25N5O8 (391.170305)


   

Thr Ser Gly Gln

(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]acetamido}-4-carbamoylbutanoic acid

C14H25N5O8 (391.170305)


   

Thr Ser Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]propanoic acid

C14H25N5O8 (391.170305)


   

Thr Ser Gln Gly

2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]acetic acid

C14H25N5O8 (391.170305)


   

Thr Thr Gly Asn

(2S)-2-{2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]acetamido}-3-carbamoylpropanoic acid

C14H25N5O8 (391.170305)


   

Thr Thr Asn Gly

2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]acetic acid

C14H25N5O8 (391.170305)


   

Pridinol methanesulfonate

Pridinol Methanesulfonate Salt

C21H29NO4S (391.1817194000001)


   
   

[2-[ethyl[4-[(4-nitrophenyl)azo]phenyl]amino]ethyl]trimethylammonium chloride

[2-[ethyl[4-[(4-nitrophenyl)azo]phenyl]amino]ethyl]trimethylammonium chloride

C19H26ClN5O2 (391.1774926)


   
   

BI-D1870

BI-D1870

C19H23F2N5O2 (391.18197219999996)


BI-D1870 is an ATP-competitive, cell permeable and brain penetrated inhibitor of RSK isoforms, with IC50s of 31 nM/24 nM/18 nM/15 nM for RSK1/RSK2/RSK3/RSK4, respectively[1][2][3][4][5].

   

Coelenterazine 400 a

Coelenterazine 400 a

C26H21N3O (391.1684536)


   

ethyl 1-cyclopropyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylate

ethyl 1-cyclopropyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylate

C20H23F2N3O3 (391.17073919999996)


   

1H-Azepine, hexahydro-1-[[[2-(4-methylphenyl)-4-quinazolinyl]thio]acetyl]- (9CI)

1H-Azepine, hexahydro-1-[[[2-(4-methylphenyl)-4-quinazolinyl]thio]acetyl]- (9CI)

C23H25N3OS (391.171824)


   

Dutogliptin tartrate

Dutogliptin tartrate

C14H26BN3O9 (391.1762016)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Diethyl 1-benzyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate

Diethyl 1-benzyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate

C24H25NO4 (391.178349)


BML-278 is a SIRT1 activator (EC150: 1 μM). BML-278 increases H3K9 methylation and inhibits H3K9 acetylation in both the paternal and maternal pronucleus. BML-278 improves early embryonic development. BML-278 arrests the cell cycle at the G1/S phase, and reduces senescence in primary human mesenchymal cells. BML-278 reduces tubulin acetylation in U937 cells. BML-278 also increases mitochondrial density in murine C2C12 myoblasts[1][2].

   

N4-(3-fluorophenyl)-N2-[3-(4-morpholinyl)propyl]-5-nitropyrimidine-2,4,6-triamine

N4-(3-fluorophenyl)-N2-[3-(4-morpholinyl)propyl]-5-nitropyrimidine-2,4,6-triamine

C17H22FN7O3 (391.17680740000003)


   

D-Glucitol, 2-(acetylmethylamino)-2-deoxy-3,6-di-O-methyl-, 1,4,5-triacetate

D-Glucitol, 2-(acetylmethylamino)-2-deoxy-3,6-di-O-methyl-, 1,4,5-triacetate

C17H29NO9 (391.1842224)


   

1-[2-[(4-Anilino-1-carboxy-4-oxobutyl)amino]propanoyl]pyrrolidine-2-carboxylic acid

1-[2-[(4-Anilino-1-carboxy-4-oxobutyl)amino]propanoyl]pyrrolidine-2-carboxylic acid

C19H25N3O6 (391.174327)


   
   
   
   
   
   

N-[[(2S,3S,4R)-3-[4-(4-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-pyridinecarboxamide

N-[[(2S,3S,4R)-3-[4-(4-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-pyridinecarboxamide

C23H22FN3O2 (391.1695964)


   

[(2S,3S)-3-phenyl-1-(3-pyridinylmethyl)-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol

[(2S,3S)-3-phenyl-1-(3-pyridinylmethyl)-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol

C21H24F3N3O (391.187137)


   

[(2S,3R)-3-phenyl-1-(3-pyridinylmethyl)-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol

[(2S,3R)-3-phenyl-1-(3-pyridinylmethyl)-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol

C21H24F3N3O (391.187137)


   
   

Benzyl 4-(furan-2-yl)-2,7,7-trimethyl-5-oxo-4,4a,6,8-tetrahydroquinoline-3-carboxylate

Benzyl 4-(furan-2-yl)-2,7,7-trimethyl-5-oxo-4,4a,6,8-tetrahydroquinoline-3-carboxylate

C24H25NO4 (391.178349)


   

(2E,4E)-1-(4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-9-yl)-4-methyl-5-phenylpenta-2,4-dien-1-one

(2E,4E)-1-(4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-9-yl)-4-methyl-5-phenylpenta-2,4-dien-1-one

C24H25NO4 (391.178349)


   

[2-[Acetyl(methyl)amino]-4,5-diacetyloxy-1-deuterio-3,6-dimethoxyhexyl] acetate

[2-[Acetyl(methyl)amino]-4,5-diacetyloxy-1-deuterio-3,6-dimethoxyhexyl] acetate

C17H29NO9 (391.1842224)


   

flavoxate

flavoxate

C24H25NO4 (391.178349)


G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D000089162 - Genitourinary Agents > D064804 - Urological Agents

   

s-Hexylglutathione

s-Hexylglutathione

C16H29N3O6S (391.17769740000006)


D004791 - Enzyme Inhibitors

   
   

2-Amino-5-((1-((carboxymethyl)amino)-3-(hexylthio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid

2-Amino-5-((1-((carboxymethyl)amino)-3-(hexylthio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid

C16H29N3O6S (391.17769740000006)


   

5,10-dihydroxy-2,11-dimethyl-2-(4-methylpent-3-en-1-yl)-1-oxa-11-azatetracen-6-one

5,10-dihydroxy-2,11-dimethyl-2-(4-methylpent-3-en-1-yl)-1-oxa-11-azatetracen-6-one

C24H25NO4 (391.178349)


   

5-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-8-methoxy-3-methyl-1,2-dihydroisoquinolin-6-ol

5-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-8-methoxy-3-methyl-1,2-dihydroisoquinolin-6-ol

C24H25NO4 (391.178349)


   

3-({1-[(4-carbamimidamidobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

3-({1-[(4-carbamimidamidobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

C18H25N5O5 (391.18556)